ConductScience.org, home

Gene · 7409

NIH grants2,874

NIH grants whose papers are about the gene, through NIH's grant-paper links.

81 to 100 of 2,874

Download this page as JSON
GrantTitleVAV1 papersNewest fiscal year
R01AI146581Modeling Antibody-induced Immune Responses by NK cells in Mice and Humans (Resubmission 1)22025
R01CA166835Targeted therapy for t(8;21)+ AML22025
R01CA175495The B7x pathways in the tumor microenvironment22025
R01CA196703Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma22025
R01CA203348Expression of recombinant Fc receptors by engineered NK cells to enhance cancer cell killing22025
R01CA265050New Therapuetics for Pancreatic Cancer22025
R01DK044319Characterization of Mucosal Lymphocytes22025
R01DK088199Endoplasmic reticulum stress and intestinal inflammation22025
R01DK095112Regulatory Role of Transferrin in Erythropoiesis and Iron Metabolism22025
R01HL134896Protection of stressed hematopoietic stem cells by the tetraspanin family member CD5322025
R01HL149883Mechanisms of regulatory T cell-mediated recovery from severe viral pneumonia22025
R01LM012806Predicting Phenotype by Deep Learning Heterogeneous Multi-Omics Data22025
R35CA197561Molecular Pathogenesis of Acute Myeloid Leukemia22025
R35CA197568Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery22025
R35GM146784Investigating the mechanisms of peroxisome homeostasis22025
R35GM146935Signal Integration during Phagocytosis22025
R37CA233476THE T-CELL RECEPTOR'S ROLE IN T-CELL LYMPHOMA PATHOGENESIS22025
R50CA211404Therapeutic insights through patient derived leukemia xenografts22025
R50CA211782Comprehensive Informatic Analyses of AML Genomes and Epigenomes22025
T32AG000222Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/7409/grants?page=5